RxDoctor Payments Data

Jie Howe, NP

Family · Fredericksburg, VANPI 1104188317

Payments from drug & device makers

$672in general payments, 2019–2025

Across 32 payments — averaging $21.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$242
  • Novo Nordisk$94
  • AstraZeneca$87
  • IBSA Pharma Inc.$45
  • Lilly USA, LLC$44
  • Exact Sciences$43
  • plus $117 from 6 others

What the payments were for

  • Food & beverage$672100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$672 in reported general payments places this provider in the 60th percentile of 4,332 family providers in Virginia.

See all family providers in Virginia

Medicare billing

Part B allowed, 2024
$52,296
Medicare patients
200
Services billed
622

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol17$26,077
JanuviaSitagliptin Phosphate17$23,423
JanumetSitagliptin Phos/Metformin Hcl15$18,931
Liothyronine Sodium62$2,425
Levothyroxine Sodium102$1,654
SynthroidLevothyroxine Sodium14$1,643
Rosuvastatin Calcium39$718
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide12$693
ProgesteroneProgesterone, Micronized14$483
Valsartan12$344
Losartan Potassium37$319
Metoprolol Succinate11$312
Metformin Hcl44$276
Montelukast Sodium12$239
Omeprazole22$212

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$87$26,07717 claims
AbbVieSynthroid$242$1,64314 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,332 family providers in Virginia.

Other family in Fredericksburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →